BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Leukocyte, Anticancer prodrugs, Clofibrate, rs2230926, FGF21, T cell differentiation)
Bookmark Forward

QuickView for INI1 (gene)


Body Atlas

Most Correlated Tissues

  1. Thymus gland
  2. Uterus
  3. Fetal liver
  4. Peritoneum
  5. Pancreas
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Placental insufficiency
  2. Fetal growth restriction
  3. Vesicular stomatitis Indiana virus disease
  4. Disorder of uterus
  5. Irritable bowel syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. NQ Y15
  2. Diquat
  3. Chromium
  4. 5'PPP-RNA
  5. 2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PTTG1
  2. MYOC
  3. LGALS4
  4. THP1
  5. MIR103A2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Splicing control by PHF5A is crucial for melanoma cell survival.
  2. AURKA/PLK1/CDC25C Axis as a Novel Therapeutic Target in INI1-Deficient Epithelioid Sarcoma.
  3. Comprehensive analysis of PHF5A as a potential prognostic biomarker and therapeutic target across ca…
  4. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
  5. Paratesticular/inguinal SMARCB1/INI1 deficient carcinomas with yolk sac tumour-like differentiation …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
  2. Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
  3. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negativ…
  4. A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory…
  5. Genetic Study of Brain Tumors in Young Children
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.